Discontinuation report ONBREZ BREEZHALER
| Report ID | 163678 |
| Drug Identification Number | 02376938 |
| Brand name | ONBREZ BREEZHALER |
| Common or Proper name | ONBREZ BREEZHALER |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | INDACATEROL |
| Strength(s) | 75MCG |
| Dosage form(s) | CAPSULE |
| Route of administration | INHALATION INHALATION |
| Packaging size | 1X 10 |
| ATC code | R03AC |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-07-01 |
| Actual discontinuation date | 2022-07-01 |
| Remaining supply date | 2022-10-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-07-14 | French | Compare |
| v4 | 2022-07-14 | English | Compare |
| v3 | 2022-06-29 | French | Compare |
| v2 | 2022-06-29 | English | Compare |
| v1 | 2022-06-29 | English | Compare |
Showing 1 to 5 of 5